Catalyst
Slingshot members are tracking this event:
NDA filling of PB272 for the extended adjuvant HER2-positive early stage breast cancer due 1Q 2016
- Source Link:
- http://www.pumabiotechnology.com/pr20151211.html
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
PBYI | Community voting in process |
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jul 27, 2016
Occurred Source:
http://www.pumabiotechnology.com/pr20160721.html
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Nda, Pb272, Her-2, Her2-positive Breast Cancer, 1q